Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

Natco Pharma unveils Everolimus tablets 1mg in US Pharma News

Natco Pharma unveils Everolimus tablets 1mg in US

  • 31 October 2025
  • 2 days ago

Natco Gets SC Nod to Launch Generic Risdiplam at 80% Lower Price, Roche Appeal Dismissed Pharma News

Natco Gets SC Nod to Launch Generic Risdiplam at 80% Lower Price, Roche Appeal Dismissed

  • 18 October 2025
  • 2 weeks ago

Roche Moves SC Against Delhi HC Nod to Natco's Rs 15,900 Generic Risdiplam for Spinal Atrophy State News

Roche Moves SC Against Delhi HC Nod to Natco's Rs 15,900 Generic Risdiplam for Spinal Atrophy

  • 16 October 2025
  • 2 weeks ago

Natco Pharma to buy significant stakes in South African Drugmaker Adcock Ingram Pharma News

Natco Pharma to buy significant stakes in South African Drugmaker Adcock Ingram

  • 13 October 2025
  • 2 weeks ago

Ongoing Sale of Covid-Era Liposomal Amphotericin B Challenged, SC Seeks Response from Top Pharma Firms, DCGI Pharma News

Ongoing Sale of Covid-Era Liposomal Amphotericin B Challenged, SC Seeks Response from Top Pharma Firms, DCGI

  • 12 October 2025
  • 3 weeks ago

Natco Pharma appoints G Vijay Kiran Kumar as VP- Corporate Quality Assurance (Formulations) Pharma News

Natco Pharma appoints G Vijay Kiran Kumar as VP- Corporate Quality Assurance (Formulations)

  • 12 October 2025
  • 3 weeks ago

Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy Pharma News

Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy

  • 11 October 2025
  • 3 weeks ago

Natco Pharma gets USFDA EIR for Kothur Pharma division Pharma News

Natco Pharma gets USFDA EIR for Kothur Pharma division

  • 18 September 2025
  • 1 month ago

Lung Cancer Drug: Natco Pharma Submits ANDA For Generic Version Of Novartis Tabrecta Oncology

Lung Cancer Drug: Natco Pharma Submits ANDA For Generic Version Of Novartis Tabrecta

  • 23 July 2025
  • 3 months ago

Recent News

Himachal notifies Resident doctor policy 2025

  • 02 November, 2025

Pfizer files lawsuit against Metsera, its Director...

  • 02 November, 2025

Health Ministry achieves 3 Guinness World Records...

  • 02 November, 2025

Roche gets CE mark for Elecsys Dengue Ag test to d...

  • 02 November, 2025

Aadhaar authentication voluntary for NBE exams, cl...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.